Highly Potent Triazole-Based Tubulin Polymerization Inhibitors

Citations Over TimeTop 10% of 2007 papers

Abstract

We describe the synthesis and biological evaluation of a series of tubulin polymerization inhibitors that contain the 1,2,4-triazole ring to retain the bioactive configuration afforded by the cis double bond in combretastatin A-4 (CA-4). Several of the subject compounds exhibited potent tubulin polymerization inhibitory activity as well as cytotoxicity against a variety of cancer cells including multi-drug-resistant (MDR) cancer cell lines. Attachment of the N-methyl-5-indolyl moiety to the 1,2,4-triazole core, as exemplified by compound 7, conferred optimal properties among this series. Computer docking and molecular simulations of 7 inside the colchicine binding site of tubulin enabled identification of residues most likely to interact strongly with these inhibitors and explain their potent anti-tubulin activity and cytotoxicity. It is hoped that results presented here will stimulate further examination of these substituted 1,2,4-triazoles as potential anti-cancer therapeutic agents.

Related Papers

• → Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: Synthesis and biological evaluation of antivascular activity(2009)188 cited
• → The interaction with tubulin of a series of stilbenes based on combretastatin A-4(1995)174 cited
• → Interaction of 4-Arylcoumarin Analogues of Combretastatins with Microtubule Network of HBL100 Cells and Binding to Tubulin(2006)73 cited
• → A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors(2020)14 cited
• → The Mechanism of the Interactions of Pironetin Analog/Combretastatin A‐4 Hybrids with Tubulin(2015)9 cited